- Home
- ASPN vs BCYC Comparison
ASPN vs BCYC Comparison
Compare ASPN & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- BCYC
- Stock Information
- Founded
- ASPN 2001
- BCYC 2009
- Country
- ASPN United States
- BCYC United Kingdom
- Employees
- ASPN N/A
- BCYC N/A
- Industry
- ASPN RETAIL: Building Materials
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- ASPN Consumer Discretionary
- BCYC Health Care
- Exchange
- ASPN Nasdaq
- BCYC Nasdaq
- Market Cap
- ASPN 570.6M
- BCYC 511.4M
- IPO Year
- ASPN 2014
- BCYC 2019
- Fundamental
- Price
- ASPN $5.56
- BCYC $8.42
- Analyst Decision
- ASPN Strong Buy
- BCYC Buy
- Analyst Count
- ASPN 11
- BCYC 8
- Target Price
- ASPN $23.20
- BCYC $29.14
- AVG Volume (30 Days)
- ASPN 1.8M
- BCYC 445.4K
- Earning Date
- ASPN 05-08-2025
- BCYC 05-05-2025
- Dividend Yield
- ASPN N/A
- BCYC N/A
- EPS Growth
- ASPN N/A
- BCYC N/A
- EPS
- ASPN 0.17
- BCYC N/A
- Revenue
- ASPN $452,699,000.00
- BCYC $35,275,000.00
- Revenue This Year
- ASPN N/A
- BCYC N/A
- Revenue Next Year
- ASPN $35.45
- BCYC $0.27
- P/E Ratio
- ASPN $32.65
- BCYC N/A
- Revenue Growth
- ASPN 89.64
- BCYC 30.76
- 52 Week Low
- ASPN $4.80
- BCYC $6.10
- 52 Week High
- ASPN $33.15
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- ASPN 41.79
- BCYC 51.30
- Support Level
- ASPN $4.96
- BCYC $8.26
- Resistance Level
- ASPN $5.59
- BCYC $9.52
- Average True Range (ATR)
- ASPN 0.39
- BCYC 0.67
- MACD
- ASPN 0.13
- BCYC 0.31
- Stochastic Oscillator
- ASPN 87.36
- BCYC 67.84
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.